Pfizer Inc. Files 8-K on Financials and Operations
Ticker: PFE · Form: 8-K · Filed: Apr 29, 2025 · CIK: 78003
| Field | Detail |
|---|---|
| Company | Pfizer Inc (PFE) |
| Form Type | 8-K |
| Filed Date | Apr 29, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-results, operations, disposal-costs
Related Tickers: PFE
TL;DR
Pfizer dropped an 8-K on April 29th covering financials, operations, and exit costs.
AI Summary
On April 29, 2025, Pfizer Inc. filed an 8-K report detailing results of operations and financial condition. The filing also covers cost associated with exit or disposal activities and includes financial statements and exhibits. The report confirms Pfizer Inc. is a Delaware-incorporated company with its principal executive offices located at 66 Hudson Boulevard East, New York, NY.
Why It Matters
This filing provides crucial updates on Pfizer's financial performance and operational activities, which can influence investor decisions and market perception.
Risk Assessment
Risk Level: low — This is a routine financial filing and does not indicate any immediate or significant risks.
Key Players & Entities
- Pfizer Inc. (company) — Registrant
- April 29, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- 66 Hudson Boulevard East, New York, NY (location) — Principal Executive Offices
- 212-733-2323 (phone_number) — Registrant's telephone number
FAQ
What specific financial results are being reported by Pfizer Inc. in this 8-K?
The filing indicates it covers 'Results of Operations and Financial Condition' but does not provide specific figures within the provided text.
What kind of 'exit or disposal activities' is Pfizer Inc. reporting costs for?
The filing mentions 'Cost Associated with Exit or Disposal Activities' but does not specify the nature of these activities in the provided text.
When was the earliest event reported in this 8-K filing?
The earliest event reported is April 29, 2025, which is also the date of the report.
What is Pfizer Inc.'s fiscal year end?
Pfizer Inc.'s fiscal year ends on December 31.
What is the Commission File Number for Pfizer Inc.'s 8-K filing?
The Commission File Number for this filing is 1-3619.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 29, 2025 regarding PFIZER INC (PFE).